Publisher
Springer Science and Business Media LLC
Reference196 articles.
1. D’Souza, A. & Fretham, C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx (2019).
2. Lundqvist, A. & Childs, R. Allogeneic hematopoietic cell transplantation as immunotherapy for solid tumors: current status and future directions. J. Immunother. 28, 281–288 (2005).
3. McDonald, G. B. et al. Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003–2007 versus 2013–2017 cohorts. Ann. Intern. Med. 172, 229–239 (2020).
4. Meybodi, M. A. et al. HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis. Blood Adv. 3, 2581–2585 (2019).
5. Passweg, J. R. et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transpl. 54, 1575–1585 (2019).
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献